Aridis Pharmaceuticals Announces Acquisition of Monoclonal Antibody Products and Technologies From Kenta Biotech
5/17/2013 9:25:33 AM
More...
|
Kenta Biotech Reports 100% Survival with Panobacumab in Life-Threatening Hospital-Acquired Pneumonia
4/15/2010 9:45:45 AM
More...
|
Kenta Biotech Announces Collaboration with Rentschler Biotechnologie GmbH & Co. for Antibody Development Against Hospital-Acquired Infections
1/14/2010 9:38:36 AM
More...
|
Kenta Biotech Reports Phase IIa Data with Lead Candidate Panobacumab in Hospital-Acquired Pneumonia
9/14/2009 10:21:11 AM
More...
|
Kenta Biotech Raises CHF 12 Million in Series B Private Financing
3/12/2009 7:52:34 AM
More...
|